Telix Pharmaceuticals Limited Increase Decrease Through Net Exchange Differences Rightofuse Assets
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease Through Net Exchange Differences Rightofuse Assets of $434.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets · last filed 2026-02-20
AUD
| Period end | Increase Decrease Through Net Exchange Differences Rightofuse Assets 12 month |
|---|---|
| 2024-12-31 | 528.00K AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | -36.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Decrease Through Net Exchange Differences Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | $434.00K 20-F · filed 2026-02-20 |
| 2024-12-31 | -$284.00K 20-F · filed 2026-02-20 |